One of the most important needs in the biopharma industry is communicators who can make the case not only for innovation but also for the broader policy and business environment

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

There is a ton of research in the journals that has hit over the past week or so. It all deserves some visibility and some thought. I’m a big fan

It’s been a nice respite over the past few days, and it’s given me some time to reflect. There is a lot I’ve been thankful for over the first full

There is just enough news here for a quick Cost Curve. I worry if I don’t put a marker down, it’ll all be swamped by the nice time I’m in

I’m paying the price for yesterday’s decision to go all-in on the Minnesota 340B report. There’s a lot to get through. Pitter patter.  Tomorrow’s Curve will be a game-time decision,

I was working through the full newsletter this morning when I saw that the Minnesota 340B report dropped. So I think it’s worth a special edition today. That doesn’t mean

Plenty of catching up to do today. Thanks for spending your Friday with me. Thank goodness it’s a bye week for the Hockey East-leading Terriers. If you want to search

Confession: after a week of what feels like daily bombshells, I fear my brain is full. There’s plenty to talk about today that has gone under-recognized or under-analyzed, but there’s